Promises kept and broken: new pharmaceuticals.
Malik
Paul
P
Queen's University, Kingston, Canada. pgmalik@hotmail.com
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001384:Azetidines / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000592:standards / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004181:Directories as Topic; D004341:Drug Evaluation; D004345:Drug Industry / Q000639:trends*; D000069438:Ezetimibe; D006801:Humans; D020407:Internet; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods; D020108:Nicorandil / Q000627:therapeutic use; D009864:Ontario; D011358:Product Surveillance, Postmarketing / Q000639:trends*; D011725:Pyridines / Q000627:therapeutic use; D013841:Thiazepines / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D001384:Azetidines; D002317:Cardiovascular Agents; D011725:Pyridines; D013841:Thiazepines; D020108:Nicorandil; C106266:omapatrilat; D000069438:Ezetimibe